Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Warner-Lambert discloses ACAT inhibitors

April 5, 1996

BMS claims beta3 agonists in patent literature

April 5, 1996

ACAT inhibitors claimed by DuPont Merck

April 5, 1996

Kyowa Hakko discloses UCF76-B

April 5, 1996

New angiogenesis inhibitors from ADIR

April 5, 1996

Merck & Co. reports farnesyl transferase inhibitors

April 5, 1996

Antineoplastic fusion proteins from Bristol-Myers Squibb

April 5, 1996

MAbs for treatment of melanoma

April 5, 1996

BMS reports mutant BR96 antibodies

April 5, 1996

Yakult Honsha claims camptothecin derivatives

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...